Research graph
References from Differential task-related fMRI effects of a single dose of guanfacine and lisdexamfetamine in youth with ADHD: a randomised, double-blind, placebo-controlled crossover study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
10.1016/j.jad.2023.07.071
10.1016/j.jad.2023.07.071 · External reference
Neural mechanisms underlying the therapeutic actions of guanfacine treatment in youth with ADHD: A pilot fMRI study
10.1016/j.pscychresns.2015.01.012 · 2015 · External reference
10.1093/ijnp/pyw049
10.1093/ijnp/pyw049 · External reference
Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder
10.1016/j.jaac.2016.05.016 · 2016 · External reference
10.1073/pnas.1520613113
10.1073/pnas.1520613113 · External reference
10.1017/s0033291714002232
10.1017/s0033291714002232 · External reference
Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study
10.1016/j.euroneuro.2015.08.024 · 2015 · External reference
Bioavailability and bioequivalence in drug development
10.1002/wics.1310 · 2014 · External reference
10.1038/mp.2011.185
10.1038/mp.2011.185 · External reference
10.1016/j.biopsych.2013.10.005
10.1016/j.biopsych.2013.10.005 · External reference
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
10.1007/s40263-017-0487-z · 2018 · External reference
Unresolved reference
External reference
10.1038/nrn755
10.1038/nrn755 · External reference
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
10.1016/s2215-0366(18)30269-4 · 2018 · External reference
10.1017/s0033291713000676
10.1017/s0033291713000676 · External reference
10.1093/cercor/bhs296
10.1093/cercor/bhs296 · External reference
10.1007/s00213-008-1337-y
10.1007/s00213-008-1337-y · External reference
10.1037/t00680-000
10.1037/t00680-000 · External reference
10.1177/1087054711427299
10.1177/1087054711427299 · External reference
10.1136/bmj.l4378
10.1136/bmj.l4378 · External reference
10.1038/s41380-026-03826-7
10.1038/s41380-026-03826-7 · External reference
Differential effects of a single dose of Lisdexamfetamine and Guanfacine on cognitive function in children with ADHD
10.3389/fpsyt.2025.1676472 · 2025 · External reference
10.1177/0956797620916786
10.1177/0956797620916786 · External reference
Neural Correlates of Verbal Working Memory: An fMRI Meta-Analysis
10.3389/fnhum.2019.00180 · 2019 · External reference
10.1111/j.1469-7610.2007.01761.x
10.1111/j.1469-7610.2007.01761.x · External reference
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
10.1007/s40261-015-0354-y · 2016 · External reference
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
10.1016/j.neubiorev.2018.02.001 · 2018 · External reference
Attention-deficit/hyperactivity disorder
10.1038/s41572-024-00495-0 · 2024 · External reference
Unresolved reference
External reference
10.1038/npp.2014.1
10.1038/npp.2014.1 · External reference
The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
10.3389/fpsyt.2021.780921 · 2022 · External reference
10.1093/gigascience/giae049
10.1093/gigascience/giae049 · External reference
10.1136/bmj-2025-085875
10.1136/bmj-2025-085875 · External reference
Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD)
10.1016/j.neubiorev.2012.08.003 · 2012 · External reference
Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder: Exploring Task-Specific, Stimulant Medication, and Age Effects
10.1001/jamapsychiatry.2013.277 · 2013 · External reference
Pattern classification of response inhibition in ADHD: Toward the development of neurobiological markers for ADHD
10.1002/hbm.22386 · 2014 · External reference
10.1371/journal.pone.0188744
10.1371/journal.pone.0188744 · External reference
10.1136/adc.84.5.404
10.1136/adc.84.5.404 · External reference
Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis
10.1016/s2215-0366(17)30049-4 · 2017 · External reference
Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples
10.1176/appi.ajp.2019.18091033 · 2019 · External reference
Unresolved reference
External reference
Visualizing Neuropharmacological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder Using Functional Near-Infrared Spectroscopy
10.3389/fnrgo.2021.657657 · 2021 · External reference
The effects of chronic administration of stimulant and non-stimulant medications on executive functions in ADHD: A systematic review and meta-analysis
10.1016/j.neubiorev.2024.105703 · 2024 · External reference
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data
10.1097/00004583-199707000-00021 · 1997 · External reference
Unresolved reference
External reference
Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder
10.1016/j.ejpn.2008.10.008 · 2009 · External reference
10.1089/cap.2010.0064
10.1089/cap.2010.0064 · External reference
10.1016/j.euroneuro.2019.07.139
10.1016/j.euroneuro.2019.07.139 · External reference
Functional MRI reveals different response inhibition between adults and children with ADHD
10.1037/neu0000200 · 2015 · External reference
10.1016/j.neuroimage.2007.07.021
10.1016/j.neuroimage.2007.07.021 · External reference
10.1017/s0033291720000574
10.1017/s0033291720000574 · External reference
Reduced inferior fronto-insular-thalamic activation during failed inhibition in young adults with combined ASD and ADHD compared to typically developing and pure disorder groups
10.1038/s41398-023-02431-4 · 2023 · External reference
Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
10.1007/s40261-013-0156-z · 2014 · External reference
10.1017/s0033291713001037
10.1017/s0033291713001037 · External reference
Evidence-based pharmacological treatment options for ADHD in children and adolescents
10.1016/j.pharmthera.2021.107940 · 2022 · External reference
10.1016/j.neuron.2023.04.023
10.1016/j.neuron.2023.04.023 · External reference
Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder
10.1016/j.jaac.2022.06.017 · 2023 · External reference
10.1002/syn.20628
10.1002/syn.20628 · External reference
The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review
10.3390/neurolint15020043 · 2023 · External reference
Psychiatric comorbidity in children and adolescents with ADHD: A systematic review and meta-analysis
10.1016/j.cpr.2025.102571 · 2025 · External reference
Structural and Functional Brain Abnormalities in Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder: A Comparative Meta-analysis
10.1001/jamapsychiatry.2016.0700 · 2016 · External reference
Shared and disorder-specific task-positive and default mode network dysfunctions during sustained attention in paediatric Attention-Deficit/Hyperactivity Disorder and obsessive/compulsive disorder
10.1016/j.nicl.2017.04.013 · 2017 · External reference
10.1016/0028-3932(71)90067-4
10.1016/0028-3932(71)90067-4 · External reference
Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis
10.1016/s2215-0366(24)00360-2 · 2025 · External reference
10.1016/j.wneu.2021.04.050
10.1016/j.wneu.2021.04.050 · External reference
Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: a comparative neuroimaging analysis
10.1017/s003329172400285x · 2024 · External reference
Unresolved reference
External reference
The Neurocognitive Profile of Attention-Deficit/Hyperactivity Disorder: A Review of Meta-Analyses
10.1093/arclin/acx055 · 2018 · External reference
10.1002/hbm.22178
10.1002/hbm.22178 · External reference
10.1016/j.brainres.2011.02.075
10.1016/j.brainres.2011.02.075 · External reference
10.1016/j.neuroimage.2019.116189
10.1016/j.neuroimage.2019.116189 · External reference
10.1007/s10802-015-0031-x
10.1007/s10802-015-0031-x · External reference
10.1176/appi.ajp.162.6.1067
10.1176/appi.ajp.162.6.1067 · External reference
10.1098/rstb.2009.0014
10.1098/rstb.2009.0014 · External reference
10.1016/j.neuropharm.2009.08.013
10.1016/j.neuropharm.2009.08.013 · External reference
10.1002/hbm.20864
10.1002/hbm.20864 · External reference
10.1016/j.biopsych.2011.04.018
10.1016/j.biopsych.2011.04.018 · External reference
Effects of age and gender on neural networks of motor response inhibition: From adolescence to mid-adulthood
10.1016/j.neuroimage.2013.06.078 · 2013 · External reference
10.1016/j.biopsych.2013.10.016
10.1016/j.biopsych.2013.10.016 · External reference
Unresolved reference
External reference
10.1136/bmj.c332
10.1136/bmj.c332 · External reference
Lisdexamfetamine Targets Amygdala Mechanisms That Bias Cognitive Control in Attention-Deficit/Hyperactivity Disorder
10.1016/j.bpsc.2018.03.004 · 2018 · External reference
10.1176/appi.ajp.161.11.1990
10.1176/appi.ajp.161.11.1990 · External reference
Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia: A Positron Emission Tomographic Functional Magnetic Resonance Imaging Study
10.1001/jamapsychiatry.2014.2414 · 2015 · External reference
10.1016/j.biopsych.2013.03.030
10.1016/j.biopsych.2013.03.030 · External reference
Different Neural Patterns Are Associated With Trials Preceding Inhibitory Errors in Children With and Without Attention-Deficit/Hyperactivity Disorder
10.1016/j.jaac.2011.03.014 · 2011 · External reference
10.1073/pnas.1407787111
10.1073/pnas.1407787111 · External reference
10.1017/s0033291716000350
10.1017/s0033291716000350 · External reference
Shared and Specific Neural Correlates of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: A Meta-Analysis of 243 Task-Based Functional MRI Studies
10.1176/appi.ajp.20230270 · 2024 · External reference
10.1016/j.neuroimage.2006.11.054
10.1016/j.neuroimage.2006.11.054 · External reference
Methylphenidate-Elicited Distinct Neuropharmacological Activation Patterns Between Medication-Naive Attention Deficit Hyperactivity Disorder Children With and Without Comorbid Autism Spectrum Disorder: A Functional Near-Infrared Spectroscopy Study
2018 · External reference
10.1093/cercor/bhw225
10.1093/cercor/bhw225 · External reference
10.1016/j.bandl.2010.03.008
10.1016/j.bandl.2010.03.008 · External reference
10.1073/pnas.95.24.14494
10.1073/pnas.95.24.14494 · External reference
10.1073/pnas.041600898
10.1073/pnas.041600898 · External reference
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
2017 · External reference
Meta-analysis: Dose-Dependent Effects of Methylphenidate on Neurocognitive Functioning in Children With Attention-Deficit/Hyperactivity Disorder
10.1016/j.jaac.2021.08.023 · 2022 · External reference
Mechanism of action of methylphenidate: Insights from PET imaging studies
10.1177/070674370200601s05 · 2002 · External reference
10.1016/j.psychres.2024.116338
10.1016/j.psychres.2024.116338 · External reference
10.1037/t15171-000
10.1037/t15171-000 · External reference
New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties
10.2147/jep.s256586 · 2020 · External reference
Meta-analysis of structural and functional alterations of brain in patients with attention-deficit/hyperactivity disorder
10.3389/fpsyt.2022.1070142 · 2023 · External reference
10.1002/hbm.21197
10.1002/hbm.21197 · External reference
